Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan-Reference-Cited by-同舟云学术

Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan

Published:2016-08 Issue: Volume:251 Page:248-254
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Teramoto Tamio,Uno Kiyoko,Miyoshi Izuru,Khan Irfan,Gorcyca Katherine,Sanchez Robert J.,Yoshida Shigeto,Mawatari Kazuhiro,Masaki Tomoya,Arai Hidenori,Yamashita Shizuya

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. World Health Organization (WHO). Global health estimates for 2000-2012: cause-specific mortality. Available from: URL: http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html (Accessed 22.06.16.).

2. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study;Yusuf;Lancet.,2004

3. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

4. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European atherosclerosis Society (EAS);Reiner;Eur. Heart J.,2011

5. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia–full report;Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members;J. Clin. Lipidol.,2014

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of prescription pattern and impact of statin in lipid profile among ischemic heart disease patients;Journal of Education and Health Promotion;2024-06

2. Clinical Pharmacology Strategy for Registration in Japan with a Case Example of Posaconazole, a Globally Approved Triazole Antifungal Drug with Broad-spectrum Antifungal Activity;Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics;2024-05-31

3. 診療ガイドライン改訂に伴う回復期脳梗塞患者における脂質管理状況の変化;Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics;2023-11-30

4. Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan;Journal of Atherosclerosis and Thrombosis;2023-11-01

5. Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial;Journal of Atherosclerosis and Thrombosis;2023